DRIEHAUS CAPITAL MANAGEMENT LLC
Institutional investor · Portfolio as of Q1 2024
Top Holdings380 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/ | 3.6M | $491.7M | 4.9% | $63.22 | +110.21% | 21 qtrssince 2019-Q1 | Increased 58 |
| 262,260 | $264.9M | 2.6% | — | — | 6 qtrssince 2022-Q4 | Decreased 0 | |
CRINETICS PHARMACEUTICALS IN | 5.2M | $244.6M | 2.4% | $21.76 | +115.14% | 16 qtrssince 2020-Q2 | Increased 55 |
XENON PHARMACEUTICALS INC | 4.3M | $186.1M | 1.9% | $26.71 | +61.18% | 17 qtrssince 2020-Q1 | Decreased 0 |
CAMTEK LTD | 2M | $164.7M | 1.6% | $63.43 | +29.94% | 3 qtrssince 2023-Q3 | Decreased 0 |
CAMECO CORP | 3.7M | $162M | 1.6% | $29.30 | +47.27% | 11 qtrssince 2021-Q3 | Increased 56 |
ICICI BANK LTD-SPON ADR | 5.9M | $155.1M | 1.5% | $17.20 | +51.04% | 21 qtrssince 2019-Q1 | Increased 54 |
AXON ENTERPRISE INC | 441,810 | $138.2M | 1.4% | $198.84 | +57.35% | 18 qtrssince 2019-Q4 | Increased 60 |
APOGEE THERAPEUTICS INC | 2.1M | $137.1M | 1.4% | $37.37 | +77.80% | 3 qtrssince 2023-Q3 | Increased 67 |
FTAI AVIATION LTD | 2M | $134.9M | 1.3% | $27.55 | +138.47% | 5 qtrssince 2023-Q1 | Decreased 0 |
SAIA INC | 221,363 | $129.5M | 1.3% | $292.61 | +99.93% | 6 qtrssince 2022-Q4 | Increased 52 |
VAXCYTE INC | 1.9M | $127.6M | 1.3% | $47.12 | +44.97% | 9 qtrssince 2022-Q1 | Increased 53 |
MONDAY COM LTD | 519,853 | $117.4M | 1.2% | $163.17 | +38.42% | 5 qtrssince 2023-Q1 | Increased 56 |
BELLRING BRANDS INC | 2M | $116.5M | 1.2% | $36.40 | +62.17% | 6 qtrssince 2022-Q4 | Increased 52 |
STRUCTURE THERAPEUTICS INC | 2.5M | $106.7M | 1.1% | $38.65 | +10.90% | 5 qtrssince 2023-Q1 | Decreased 0 |
CYBERARK SOFTWARE LTD | 368,291 | $97.8M | 1.0% | $179.54 | +47.95% | 10 qtrssince 2021-Q4 | Increased 46 |
NATERA INC | 1.1M | $97.4M | 1.0% | $63.71 | +43.56% | 7 qtrssince 2022-Q3 | Increased 59 |
ONTO INNOVATION INC | 525,441 | $95.1M | 0.9% | $136.01 | +33.14% | 3 qtrssince 2023-Q3 | Decreased 0 |
TransMedics Group, Inc. | 1.3M | $94.9M | 0.9% | $49.19 | +50.32% | 8 qtrssince 2022-Q2 | Increased 49 |
e.l.f. Beauty, Inc. | 473,616 | $92.8M | 0.9% | $34.39 | +470.10% | 9 qtrssince 2022-Q1 | Decreased 0 |
DRIEHAUS CAPITAL MANAGEMENT LLC manages $10B across 380 positions as of Q1 2024. Top holdings: TSM (4.9%), MS5 (2.6%), CRNX (2.4%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2/5.0.
Active quarter - 86 new positions, 83 exits, 125 increased. Top move: APGE (INCREASED, conviction 67). Portfolio: $10.0B across 380 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer